Dexcom, a San Diego biotech company known for its continuous glucose monitoring systems, is laying off a few hundred workers as it relocates its operations and manufacturing from California to Arizona.
The company announced 319 layoffs in a WARN notice to California officials on August 27, as is generally required in the event of mass layoffs. On Wednesday, spokesperson James McIntosh notified SFGATE that the WARN number represents the company’s U.S. layoffs, and that around 31 more workers are being laid off abroad, for a total of 3% of the overall workforce.
McIntosh stated 196 workers are losing their jobs in San Diego, where the company is headquartered and still bases its product innovation work. Dexcom stated in 2024 that it would be shifting its manufacturing business from there to Arizona.
“Part of this alter to our organizational model and operating structure includes the elimination of 134 operations roles in San Diego as we continue transitioning our manufacturing and operations business from San Diego to Mesa, Arizona,” McIntosh wrote.
The WARN document reveals that several vice presidents and senior directors, as well as a slew of other managers, are losing their jobs in the layoff. Dozens of manufacturing associates, 29 people with the role “associate district account representative” and 19 material handlers are also on the list. They’ll officially lose their jobs on Nov. 3, the document stated.
Beyond the eastward shift, McIntosh’s statement explained the cut as a necessary business relocate: “These alters are focapplyd on reinvesting in key areas that drive future growth and sustainability and are designed to ensure Dexcom remains a leader in health technology — keeping us focapplyd on our mission to empower people to take control of health.”
Dexcom, which started the year with around 10,300 employees, has iterated for years on its continuous glucose monitoring devices, letting diabetes patients avoid pricking their fingers for periodic blood tests. With diabetes’ ubiquity, these devices are huge business — Dexcom touted a $180 million profit on about $1.2 billion in revenue in its last quarterly earnings report. The company is worth about $30 billion.
The biotech company’s workers may find this moment familiar; Dexom laid off 536 workers just last year, per the San Diego Union-Tribune, when the company decided to pull manufacturing out of San Diego and relocate it to the growing facility in Mesa.
Leave a Reply